講演情報
[P1-41]Confidential
*Yohei Uchida1, Rika Nakahashi1,2, Shingo Umemoto1,3, Hiroshi Kiyono1,2,4,5,6,7 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan), 2. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University (Japan), 3. Department of Otorhinolaryngology and Head & Neck Surgery, Faculty of Medicine, Oita University (Japan), 4. Future Medicine Education and Research Organization, Chiba University (Japan), 5. Department of Medicine, UC San Diego School of Medicine (United States of America), 6. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine (United States of America), 7. Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University (Japan))
